List of Asuragen patents

Patents where

Current Assignee

Name

Asuragen

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9506061 Methods and compositions involving miRNA and miRNA inhibitor molecules	Patent 9506061 was granted and assigned to Asuragen on November, 2016 by the United States Patent and Trademark Office.	Asuragen	Asuragen	United States Patent and Trademark Office	9506061	November 29, 2016
‌ US Patent 8465914 Method and compositions involving microRNA	Patent 8465914 was granted and assigned to Asuragen on June, 2013 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	8465914	June 18, 2013
‌ US Patent 8679757 PCR methods for characterizing the 5′ untranslated region of the FMR1 and FMR2 genes	Patent 8679757 was granted and assigned to Asuragen on March, 2014 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	8679757	March 25, 2014
‌ US Patent 9777330 mPCR methods for analyzing repeat sequences	Patent 9777330 was granted and assigned to Asuragen on October, 2017 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	9777330	October 3, 2017
‌ US Patent 8735074 MiRNA biomarkers of lung disease	Patent 8735074 was granted and assigned to Asuragen on May, 2014 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	8735074	May 27, 2014
‌ US Patent 11236384 Methods of RNA amplification	Patent 11236384 was granted and assigned to Asuragen on February, 2022 by the United States Patent and Trademark Office.	Asuragen	Asuragen	United States Patent and Trademark Office	11236384	February 1, 2022
‌ US Patent 8409805 Method of amplification of GC-rich DNA templates	Patent 8409805 was granted and assigned to Asuragen on April, 2013 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	8409805	April 2, 2013
‌ US Patent 7993831 Methods of normalization in microRNA detection assays	Patent 7993831 was granted and assigned to Asuragen on August, 2011 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	7993831	August 9, 2011
‌ US Patent 9051571 Methods and compositions involving miRNA and miRNA inhibitor molecules	Patent 9051571 was granted and assigned to Asuragen on June, 2015 by the United States Patent and Trademark Office.	Asuragen	Asuragen	United States Patent and Trademark Office	9051571	June 9, 2015
‌ US Patent 9068219 Methods and compositions involving miRNA and miRNA inhibitor molecules	Patent 9068219 was granted and assigned to Asuragen on June, 2015 by the United States Patent and Trademark Office.	Asuragen	Asuragen	United States Patent and Trademark Office	9068219	June 30, 2015
‌ US Patent 9382537 Methods and compositions involving miRNA and miRNA inhibitor molecules	Patent 9382537 was granted and assigned to Asuragen on July, 2016 by the United States Patent and Trademark Office.	Asuragen	Asuragen	United States Patent and Trademark Office	9382537	July 5, 2016
‌ US Patent 9447414 Methods and compositions involving miRNA and miRNA inhibitor molecules	Patent 9447414 was granted and assigned to Asuragen on September, 2016 by the United States Patent and Trademark Office.	Asuragen	Asuragen	United States Patent and Trademark Office	9447414	September 20, 2016
‌ US Patent 8058250 Methods and compositions involving miRNA and miRNA inhibitor molecules	Patent 8058250 was granted and assigned to Asuragen on November, 2011 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	8058250	November 15, 2011
‌ US Patent 8173611 Methods and compositions involving miRNA and miRNA inhibitor molecules	Patent 8173611 was granted and assigned to Asuragen on May, 2012 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	8173611	May 8, 2012
‌ US Patent 7960359 Methods and compositions involving miRNA and miRNA inhibitor molecules	Patent 7960359 was granted and assigned to Asuragen on June, 2011 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	7960359	June 14, 2011
‌ US Patent 7919245 Methods and compositions involving microRNA	Patent 7919245 was granted and assigned to Asuragen on April, 2011 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	7919245	April 5, 2011
‌ US Patent 9783848 PCR methods for characterizing the 5′ untranslated region of the FMR1 and FMR2 genes	Patent 9783848 was granted and assigned to Asuragen on October, 2017 by the United States Patent and Trademark Office.	Asuragen	Asuragen	United States Patent and Trademark Office	9783848	October 10, 2017
‌ US Patent 11214829 Methods, compositions, kits, and uses for analysis of nucleic acids comprising repeating A/T-rich segments	Patent 11214829 was granted and assigned to Asuragen on January, 2022 by the United States Patent and Trademark Office.	Asuragen	Asuragen	United States Patent and Trademark Office	11214829	January 4, 2022
‌ US Patent 9371560 Comprehensive FMR1 genotyping	Patent 9371560 was granted and assigned to Asuragen on June, 2016 by the United States Patent and Trademark Office.	Asuragen	Asuragen	United States Patent and Trademark Office	9371560	June 21, 2016
‌ US Patent 8568971 Methods and compositions involving microRNA	Patent 8568971 was granted and assigned to Asuragen on October, 2013 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	8568971	October 29, 2013
‌ US Patent 7888010 Methods and compositions involving microRNA	Patent 7888010 was granted and assigned to Asuragen on February, 2011 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	7888010	February 15, 2011
‌ US Patent 9080215 MicroRNAs differentially expressed in cervical cancer and uses thereof	Patent 9080215 was granted and assigned to Asuragen on July, 2015 by the United States Patent and Trademark Office.	Asuragen	Asuragen	United States Patent and Trademark Office	9080215	July 14, 2015
‌ US Patent 8765709 Methods and compositions involving miRNA and miRNA inhibitor molecules		Asuragen	Asuragen	United States Patent and Trademark Office	8765709	July 1, 2014
‌ US Patent 8361714 Micrornas differentially expressed in cervical cancer and uses thereof	Patent 8361714 was granted and assigned to Asuragen on January, 2013 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	8361714	January 29, 2013
‌ US Patent 8003320 Methods and compositions involving MicroRNA	Patent 8003320 was granted and assigned to Asuragen on August, 2011 by the United States Patent and Trademark Office.		Asuragen	United States Patent and Trademark Office	8003320	August 23, 2011

Results per page:

29 results

0 selected

29 results

0 selected